New Triple-Threat attack on advanced colon cancer
NCT ID NCT05217446
Summary
This study is testing whether adding two targeted drugs (encorafenib and cetuximab) to an immunotherapy drug (pembrolizumab) works better than the immunotherapy alone for people with a specific type of advanced colorectal cancer that has spread. It is for adults whose cancer has not been treated before and has certain genetic features. The goal is to see if the combination can better control the cancer's growth and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Grande Ospedale Metropolitano Niguarda
Milan, Milano, 20162, Italy
-
Aalborg Universitetshospital, Syd
Aalborg, North Denmark, 9000, Denmark
-
Aberdeen Royal Infirmary
Aberdeen, Aberdeen CITY, AB25 2ZN, United Kingdom
-
Arcispedale Santa Maria Nuova
Reggio Emilia, 42123, Italy
-
Austin Health
Heidelberg, Victoria, 3084, Australia
-
Azienda Ospedaliera Universitaria dell'Università "Luigi Vanvitelli" Piazza Luigi Miraglia, 2 Napoli
Naples, Campania, 80131, Italy
-
Azienda Ospedaliero Universitaria Pisana
Pisa, Tuscany, 56126, Italy
-
Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno
Livorno, Tuscany, 57124, Italy
-
CHU Estaing
Clermont-Ferrand, 63100, France
-
CHUS - Hospital Clinico Universitario
Santiago de Compostela, A Coruña [LA Coruña], 15706, Spain
-
Centre Hospitalier Universitaire Estaing
Clermont-Ferrand, 63100, France
-
Cliniques universitaires Saint-Luc
Brussels, Bruxelles-capitale, Région de, 1200, Belgium
-
Facharztzentrum Eppendorf
Hamburg, 20249, Germany
-
Fakultni Thomayerova nemocnice
Prague, Praha 4, 14059, Czechia
-
Fakultni nemocnice Bulovka
Prague, Praha 8, 180 81, Czechia
-
Fakultni nemocnice Hradec Kralove
Hradec Králové, Hradec Králové, 500 05, Czechia
-
Fondazione Poliambulanza Istituto Ospedaliero
Brescia, 25124, Italy
-
Heartlands Hospital
Birmingham, B9 5SS, United Kingdom
-
Herlev and Gentofte Hospital
Copenhagen, Capital Region, 2730, Denmark
-
Hospital Clínic de Barcelona
Barcelona, Catalunya [cataluña], 08036, Spain
-
Hospital General Universitario Gregorio Marañon
Madrid, 28007, Spain
-
Hospital General Universitario de Valencia
Valencia, 46014, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [barcelona], 08035, Spain
-
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Comunidad de, 28034, Spain
-
Hospital Universitario Virgen Del Rocio
Seville, 41013, Spain
-
Hôpital Européen Georges Pompidou
Paris, Paris, 75015, France
-
Hôpital Saint Antoine
Paris, 75571, France
-
IRCCS Casa Sollievo della Sofferenza
San Giovanni Rotondo, Foggia, 71013, Italy
-
Imelda General Hospital
Bonheiden, Antwerpen, 2820, Belgium
-
Institut Català d'Oncologia - L'Hospitalet
L'Hospitalet de Llobregat, Catalunya [cataluña], 08908, Spain
-
Institut Jules Bordet
Anderlecht, Bruxelles-capitale, Région de, 1070, Belgium
-
Institut Regional du Cancer de Montpellier - ICM Val d'Aurelle
Montpellier, 34298, France
-
Istituto Europeo di Oncologia IRCCS
Milan, 20141, Italy
-
Istituto Oncologico Veneto IRCCS
Padua, Veneto, 35128, Italy
-
Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia
Candiolo, Torino, 10060, Italy
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Maastricht UMC+
Maastricht, Limburg, 6229 HX, Netherlands
-
Mayo Clinic
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic Building - Phoenix
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Hospital
Phoenix, Arizona, 85054, United States
-
Mount Sinai Cancer Center
Miami Beach, Florida, 33140, United States
-
Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie
Munich, Bavaria, 81737, Germany
-
Narodny onkologicky ustav
Bratislava, 833 10, Slovakia
-
Oslo Universitetssykehus Ullevål
Oslo, 0450, Norway
-
Ospedale di Guastalla
Guastalla, Emilia-Romagna, 42016, Italy
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Policlinico Universitario Monserrato
Monserrato, Cagliari, 09042, Italy
-
Przychodnia Lekarska KOMED
Konin, Greater Poland Voivodeship, 62-500, Poland
-
Rigshospitalet
Copenhagen, Capital Region, 2100, Denmark
-
Royal Melbourne Hospital
Parkville, Victoria, 3052, Australia
-
Saskatoon Cancer Center
Saskatoon, Saskatchewan, S7N4H4, Canada
-
Saskatoon City Hospital
Saskatoon, Saskatchewan, S7K 0M7, Canada
-
Sunnybrook Health Sciences - Odette Cancer Centre
Toronto, Ontario, M4N 3M5, Canada
-
Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
Brzozów, 36-200, Poland
-
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
-
The West Clinic, PLLC dba West Cancer Center
Germantown, Tennessee, 38138, United States
-
Vejle Hospital, Department of Oncology
Vejle, Region Syddanmark, 7100, Denmark
-
Vejle Sygehus
Vejle, Region Syddanmark, 7100, Denmark
Conditions
Explore the condition pages connected to this study.